BioDelivery Sciences International Inc logo

BDSI - BioDelivery Sciences International Inc News Story

$3.38 0.2  6.5%

Last Trade - 07/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £244.0m
Enterprise Value £220.3m
Revenue £112.0m
Position in Universe 4014th / 6858

BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva

Tue 6th February, 2018 12:00pm
Feb 6 (Reuters) - Biodelivery Sciences International Inc 
 BDSI.O : 
    * BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION 
SETTLEMENT AGREEMENT WITH TEVA 
    * BIODELIVERY SCIENCES - ENTERED INTO SETTLEMENT AGREEMENT 
WITH 
TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICALS 
INDUSTRIES, LTD. 
    * BIODELIVERY SCIENCES - AGREEMENT RESOLVES BELBUCA 
(BUPRENORPHINE) BUCCAL FILM (CIII), PATENT LITIGATION AGAINST 
TEVA 
 
Source text for Eikon:  ID:nGNXOMWYQa  
Further company coverage:  BDSI.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.